Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$629M |
| 2 |
AGN
Allergan plc
AGN
|
+$463M |
| 3 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$350M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$315M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$978M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$675M |
| 3 |
Apple
AAPL
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$387M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$344M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.7% |
| 2 | Healthcare | 5.71% |
| 3 | Financials | 4.62% |
| 4 | Consumer Discretionary | 4.5% |
| 5 | Communication Services | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESSA
5526
DELISTED
ESSA Bancorp
ESSA
| $80K | ﹤0.01% |
4,853
-1,440
| -23% | -$22.1K |
|
5527
PUT
Principal Financial Group
PFG
$24.3B
| $80K | ﹤0.01% |
1,400
-700
| -33% | -$39.4K |
|
5528
Riverview Bancorp
RVSB
$107M
| $80K | ﹤0.01% |
10,914
-20,467
| -65% | -$159K |
|
|
SPPI
5529
PUT
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $80K | ﹤0.01% |
9,600
-216,300
| -96% | -$1.75M |
|
|
ENDP
5530
PUT
DELISTED
Endo International plc
ENDP
| $80K | ﹤0.01% |
24,900
+200
| +0.8% | +$645 |
|
|
IMMU
5531
PUT
DELISTED
Immunomedics Inc
IMMU
| $80K | ﹤0.01% |
6,000
-9,600
| -62% | -$141K |
|
5532
Donegal Group Class A
DGICA
$731M
| $79K | ﹤0.01% |
5,370
-1,502
| -22% | -$21.9K |
|
|
AGNT
5533
AGNT Inc
AGNT
$666M
| $79K | ﹤0.01% |
18,660
-1,902
| -9% | -$9.03K |
|
5534
PUT
FMC
FMC
$1.34B
| $79K | ﹤0.01% |
900
-1,000
| -53% | -$85.8K |
|
5535
Hovnanian Enterprises
HOV
$726M
| $79K | ﹤0.01% |
4,066
+3,999
| +5,969% | +$38.1K |
|
5536
CALL
IDT Corp
IDT
$1.64B
| $79K | ﹤0.01% |
7,500
-500
| -6% | -$4.99K |
|
5537
Seres Therapeutics
MCRB
$46.8M
| $79K | ﹤0.01% |
987
+264
| +37% | +$17.4K |
|
5538
PUT
Stratasys
SSYS
$679M
| $79K | ﹤0.01% |
3,700
-3,500
| -49% | -$88.4K |
|
5539
Stagwell
STGW
$2.07B
| $79K | ﹤0.01% |
27,888
-8,585
| -24% | -$21.5K |
|
|
RLH
5540
DELISTED
Red Lions Hotel Corporation
RLH
| $79K | ﹤0.01% |
12,247
-3,538
| -22% | -$22.1K |
|
|
DNBF
5541
DELISTED
DNB Financial Corp
DNBF
| $79K | ﹤0.01% |
1,788
-524
| -23% | -$22.9K |
|
5542
Esquire Financial Holdings
ESQ
$1.12B
| $78K | ﹤0.01% |
3,148
-961
| -23% | -$23K |
|
5543
Perion Network
PERI
$375M
| $78K | ﹤0.01% |
16,000
+15,890
| +14,445% | +$77.7K |
|
5544
CALL
SM Energy
SM
$7.8B
| $78K | ﹤0.01% |
8,100
-1,900
| -19% | -$19.4K |
|
5545
PUT
Snap-on
SNA
$21.2B
| $78K | ﹤0.01% |
500
-4,300
| -90% | -$661K |
|
5546
Scholar Rock
SRRK
$5.67B
| $78K | ﹤0.01% |
8,711
-1,286
| -13% | -$15.4K |
|
5547
PUT
Viavi Solutions
VIAV
$9.12B
| $78K | ﹤0.01% |
5,600
+4,900
| +700% | +$69.7K |
|
5548
Yatra Online
YTRA
$52.7M
| $78K | ﹤0.01% |
19,019
-73,481
| -79% | -$304K |
|
|
VIA
5549
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $78K | ﹤0.01% |
1,467
-174
| -11% | -$9.17K |
|
|
PZN
5550
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $78K | ﹤0.01% |
8,707
-2,679
| -24% | -$22.3K |
|
Similar funds
Barclays's Q3 2019 Portfolio in Review
As of Q3 2019, Barclays held 7,551 positions worth $160B, down 2.1% from $163B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays's Q3 2019 filing shows 501 new, 2,626 increased, 3,452 reduced and 568 closed positions. Its largest new stake was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $978M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.5% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2019 buy was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M.
- Barclays added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2019, an estimated $629M increase.
- Barclays's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $978M.
- Barclays fully exited Anadarko Petroleum in Q3 2019, selling an estimated $309M.
- Barclays's ten largest holdings make up 28% of its $160B portfolio in Q3 2019.
- Barclays opened 501 new positions and closed 568 in Q3 2019.
- Barclays's portfolio value fell 2.1% quarter-over-quarter to $160B.
Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.